Objective:Three protease-activated receptor (PAR1, 3, and 4) isoforms have been shown to be responsible for the cellular effects of thrombin; another PAR isoform (PAR2) is responsible for the cellular effects of trypsin. The present studies sought to test the hypothesis that one (or more) of these PAR isoforms is expressed in myometrial tissue, thereby accounting for the uterotonic effects of these novel agonists.
Methods:The rat PAR3 and 4 isoforms were cloned from a rat spleen cDNA library. PAR isoform mRNA expression was determined by using reverse-transcriptase polymerase chain reactions (PCR) in Sprague-Dawley rats. Confirmation of the identity of the amplified mRNA was done by sequence analysis. Relative quantification of the PAR1 and PAR2 isoforms was performed using a real-time quantitative reverse transcriptase PCR (RT-PCR) technique. PAR protein expression was confirmed by Western blots using polyclonal antibodies.
Results:The rat PAR3 and 4 homologues showed significant sequence homology to the mouse and human amino acid and nucleotide sequences. The RT-PCR studies confirmed PAR1-4 expression in myometrium from rats in estrus. PAR3 was expressed in uterus, spleen, kidney, liver, lung, brain, and heart. PAR4 was expressed in uterus, spleen, and lung. Messenger RNA for the PAR1 and 2 isoforms was expressed during the second half of gestation in myometrium from timed-pregnant rats. In contrast, mRNA for the PAR3 and 4 isoforms was not detected in gestational myometrium. PAR protein expression appeared to match tissue mRNA expression patterns.
Conclusion:These RT-PCR studies confirmed ubiquitous expression of the PAR1 and PAR2 isoforms in myometrium and other rat tissues; in contrast, the PAR3 and PAR4 isoforms are expressed in a tissue-specific and gestationally related pattern.
1. Fareed J, Kindel G, Kumar A. Modulation of smooth muscle responses by serine proteases and related enzymes. Semin Thromb Hemost1986;12:265-276.
2.
2. Nakayama K, Hashimoto K. Blood components and cerebral vasopasm. Bibl Cardiol1984;38:148-160.
3.
3. Hauck RW, Schulz C, Schomig A, Hoffman RK, Panettieri RA Jr. alpha-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. Am J Physiol1999;277:L22-L29.
4.
4. Jerius H, Beall A, Woodrum D, Epstein A, Brophy C. Thrombin-induced vasospasm: Cellular signaling mechanisms. Surgery1998;123:46-50.
5.
5. Grand RJ, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J1996;313:353-368.
6.
6. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol1998;274:C1429-C1452.
7.
7. Bohm SK, McConalogue K, Kong W, Bunnett NW. Proteinase-activated receptors: New function for old enzymes. New Physiol Sci1998;13:231-240.
8.
8. Kahn ML, Hammes SR, Botka C, Coughlin SR. Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J Biol Chem1998;273(36):23290-23296.
9.
9. Ishihara H, Connolly AJ, Zeng D, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature1997;386(6624):502-506.
10.
10. Elovitz M, Saunders T, Ascher-Landsberg J, Phillippe M. Effects of thrombin on myometrial contractions, in vitro and in vivo. Am J Obstet Gynecol2000;183:799-804.
11.
11. Elovitz M, Ascher-Landsberg J, Saunders T, Phillippe M. Thrombin, the mechanisms underlying its stimulatory effects on myometrial smooth muscle. Am J Obstet Gynecol2000;183:674-681.
12.
12. Phillippe M, Saunders T, Basa A. Intracellular mechanisms underlying prostaglandin F2alpha-stimulated phasic myometrial contractions. Am J Physiol1997;273:E665-E673.
13.
13. Phillippe M, Chien EK. Intracellular signaling and phasic myometrial contractions. J Soc Gynecol Investig1998;5:169-177.
14.
14. Schrey MP, Conford PA, Read AM, Steer PJ. A role for phosphoinositide hydrolysis in human uterine smooth muscle during parturition. Am J Obstet Gynecol1988;159:964-970.
15.
15. Young RC, Hession RO. Intra-and intercellular calcium waves in cultured human myometrium. J Muscle Res Cell Motil1996;17:349-355.
16.
16. Ku CY, Qian A, Wen Y, Anwer K, Sanborn BM. Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11. Endocrinology1995;136:1509-1515.
17.
17. Uszynski M, Rutkowska L. Oxytocic action of thrombin on the rat uterus in vitro. Ginekol Pol1975;46:783-786.
18.
18. Shintani Y, Hirano K, Nishimura J, Nakano H, Kanaide H. Enhanced contractile response to thrombin in the pregnant rat myometrium. Br J Pharm2000;131:1619-1628.
19.
19. Altschul SF, Madden TL, Schaffer AA, Zhang J, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acid Res1997;28:243-245.
20.
20. Zhong C, Hayzer DJ, Corson MA, Runge MS. Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem1992;267:16975-16979.
21.
21. Saifeddine M, al-Ani B, Cheng CH, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol1996;118:521-530.
22.
22. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res1996;6:986-994.
23.
23. Kim TK, Saunders T, Bieber E, Phillippe M. Tissue-specific protein kinase C isoform expression in rat uterine tissue. J Soc Gynecol Investig1999;6:293-300.
24.
24. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell1991;64:1057-1068.
25.
25. Coughlin SR, Vu TK, Hugh DT. Wheaton VI. Characterization of a functional thrombin receptor. Issues and opportunities. J Clin Invest1992;89:351-355.
26.
26. Kahn M, Ishii K, Kuo WL, et al. Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster. Mol Med1996;2:349-357.
27.
27. Nystedt S, Larsson AK, Aberg H, Sundelin J. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J Biol Chem1995;270:5950-5955.
28.
28. Delorme MA, Burrows RF, Ofosu FA, Andrew M. Thrombin regulation in mother and fetus during pregnancy. Semin Thromb Hemost1992;18(1):81-90.
29.
29. Xu WF, Andersen H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A1998;95:6642-6646.
30.
30. Perry KG Jr, Martin JN Jr. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol1992;35(2):338-350.
31.
31. Mao SJ, Yates MT, Owen TJ, Krstenansky JL. Interaction of hirudin with thrombin: Identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry1988;27:8170-8173.
32.
32. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature2000;404:609-613.
33.
33. Ishihara H, Zeng D, Connolly AJ, Tam C, Coughlin SR. Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. Blood1998;91:4152-4157.
34.
34. Xu WF, Anderson H, Whitmore TE, et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A1998;95:6642-6646.
35.
35. Rudolph MI, Cabanillas A, Gomez P, Garcia MA, Villan L. On the mechanism of action of ethodin in inducing myometrium contractions. Gen Pharmacol1997;28:381-385.
36.
36. Rudolph MI, de los Angeles Garcia M, Sepulveda M, et al. Ethodin: Pharmacological evidence of the interaction between smooth muscle and mast cells in the myometrium. J Pharmacol Exp Ther1997;282:256-261.
